Charged-particle therapy in cancer: clinical uses and future perspectives
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.30
Published Online: 2017-03-14
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Durante, Marco
Orecchia, Roberto
Loeffler, Jay S.
Text and Data Mining valid from 2017-03-14
Version of Record valid from 2017-03-14
Article History
First Online: 14 March 2017
Competing interests
: J.S.L. declares an association with ProCure Proton Therapy. R.O. and M.D. declare no competing interests.